ACC Reps sticking or bailing?













Net sales of the Precedex® intensive care sedative (dexmedetomidine) were down by 29% in January-June 2014 at EUR 16 (23) million. In the United States and markets outside Europe the sedative is sold by Orion's partner Hospira. Following the expiry of the Precedex basic patent in the United States in January, the level of royalties received by Orion from Hospira decreased and consequently the sales recorded by Orion have decreased. About four-fifths of net sales of Precedex are in US markets, where generic competition has not commenced.


If it isn't the pot calling the kettle black! Our main business efforts is to make generics of other companies' products ---- thus putting them in the same circumstance that we are in with Precedex. Either we take our fair share of pain when it is our turn or we look like a bunch of crybabies! Suck it up or get out of the game.
 






It might be stormy now, but it can't rain forever ! Hardships often prepare ordinary people for an extraordinary destiny. Take pride in how far you have come and have faith in how far you can go

hr4u

Oh thank you for your inspirational words of wisdom . They almost made me puke. You are one piece of work..... Or is it shit?
 












The two managers that aren't really managers, are still at same pay grade and their title is STILL the same. As far as 70 bumped now, it ain't happening! I told you, and HSP press release told you 130 are gone The layoff WILL be executed all at once !The following is Hospiras View of what it feels will happen to the WHOLE company after Precedex Loss :eek:->
"Hospira urgently needs an injunction pending decision of this appeal In the absence of injunction relief, Hospira will suffer irreparable harm, harm which will not and cannot be undone even if Hospira prevails in this appeal"


:eek:You shouldn't dwell on things beyond your control, Go with the flow and it will work out in the end for the Better[b/]:eek:


So it shall pass